TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05025020

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: interactive 3D tool
Description: The study tool displays 3-dimensional step-by-step animations of autologous and implant-based breast reconstruction procedures.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: BREAST-Q Reconstruction Module
Description: The BREAST-Q Reconstruction Module1-3 has 6 domains that cover various aspects of patient satisfaction and quality of life. BREAST-Q is part of our standard of care for patients treated for breast cancer and referred for reconstruction.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BREAST-Q Reconstruction Module
Description: The BREAST-Q Reconstruction Module1-3 has 6 domains that cover various aspects of patient satisfaction and quality of life. BREAST-Q is part of our standard of care for patients treated for breast cancer and referred for reconstruction.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: DQI
Description: The DQI has 3 domains that cover decision-specific questions about what it is like for a patient to make decisions about reconstruction after breast cancer treatment.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DQI
Description: The DQI has 3 domains that cover decision-specific questions about what it is like for a patient to make decisions about reconstruction after breast cancer treatment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ottawa Decision Regret Scale
Description: The validated Decision Regret Scale measures distress or remorse after a health care decision by the use of 5 items to indicate the extent to which the respondent agrees or disagrees with the statements in the regret scale.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ottawa Decision Regret Scale
Description: The validated Decision Regret Scale measures distress or remorse after a health care decision by the use of 5 items to indicate the extent to which the respondent agrees or disagrees with the statements in the regret scale.
Study: NCT06599775

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab injection
Description: Experimental group：Adebrelimab is an innovative PD-L1 inhibitor, monotherapy can improve pathological complete response rates with tolerable safety

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-Bound Paclitaxel
Description: Experimental group：combined with Adebrelimab（PD-L1 inhibitor）,and carboplatin followed by endoscopic resection and subsequent simultaneous radiotherapy combined with albumin-bound paclitaxel and carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin injection
Description: Experimental group：combined with Adebrelimab（PD-L1 inhibitor），and albumin-bound paclitaxel followed by endoscopic resection and subsequent simultaneous radiotherapy combined with albumin-bound paclitaxel and carboplatin
Study: NCT06702319

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Home exercises and home exercises with internal focus exercises or external focus exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Home exercises and home exercises with internal focus exercises or external focus exercises
Study: NCT06706284

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide Injectable Product
Description: A GLP-1 inhibitor used to control T2DM

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline solution will be administered with the same frequency as semaglutide and participants will be instructed how to use the saline in the same manner as the active drug group.
Study: NCT06704165

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment using double slot bracket wire in high level slot
Description: patients will receives the new treatment therapy by using Double slot bracket with the wire in low level for the treatment of anterior deep bite .

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment using double slot bracket with wire in low level slot
Description: patients will receives the new treatment therapy by using Double slot bracket with the wire in high level for the treatment of anterior deep bite .
Study: NCT06705855

Intervention type: DEVICE
Intervention: NIRS sensor placement
Description: After written informed consent, the patient will be brought to the operating room. Skin tone will be assessed using the Monk scale. Prior to induction of general anesthesia, the right kidney will be located by surface ultrasound, the distance between the renal capsule and the skin will be measured, and a NIRS sensor will be placed on the skin overlaying the kidney. If the patient has had a right nephrectomy, the left kidney will be used. Additional NIRS sensors will then be placed over the patient's ipsilateral biceps and vastus lateralis muscles. The distance from the skin to the muscle tissue will be measured and recorded using ultrasound. NIRS sensors will also be placed on the patient's forehead to measure cerebral oximetry as is current practice at our institution for all cardiac surgeries requiring cardiopulmonary bypass.
Study: NCT06705829

Intervention type: BIOLOGICAL
Intervention: Prothrombin
Description: Comparison of prothrombin time results obtained with the different thromboplastins reagent for subgroup (extrinsic pathway factor and for those with hepatocellular insufficiency) by a regression line and a Bland-Altman representation.~Comparison of extrinsic pathway factor assays obtained with the different thromboplastins reagent for each subgroup by a regression line and a Bland-Altman representation.~Evaluation and determination of the sensitivity of the prothrombin time according to the activity rate obtained for each factor (for each reagent).
Study: NCT06704659

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Breast conserving surgey and radiotherapy
Description: The patients will undergo repeat Breast Conserving Surgery and Radiotherapy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mastectomy
Description: The patients will undergo mastectomy
Study: NCT05123001

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biostrap arm band
Description: The Biostrap mobile app will connect with the Biostrap arm band and temperature sensor.
Study: NCT06305364

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gixam
Description: Participants will be required to extend their tongue in the Gixam device. Six images will be obtained and analyzed by the artificial intelligence (AI) model generating a prediction score for the presence of colorectal adenoma.
Study: NCT06519942

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling
Description: Fasting blood samples will be obtained.

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling
Description: Fasting blood samples will be obtained.

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling
Description: Fasting blood samples will be obtained.

Intervention type: DIAGNOSTIC_TEST
Intervention: Electromyoneurography (EMNG)
Description: Nerve conduction of sensory and motor nerves of the upper and lower limb will be performed, including F- and H-waves. Needle EMNG of the m. tibialis anterior, m. gastrocnemius (medial head), m. tensor fascia lata and m. gluteus maximus) will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Electromyoneurography (EMNG)
Description: Nerve conduction of sensory and motor nerves of the upper and lower limb will be performed, including F- and H-waves. Needle EMNG of the m. tibialis anterior, m. gastrocnemius (medial head), m. tensor fascia lata and m. gluteus maximus) will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Electromyoneurography (EMNG)
Description: Nerve conduction of sensory and motor nerves of the upper and lower limb will be performed, including F- and H-waves. Needle EMNG of the m. tibialis anterior, m. gastrocnemius (medial head), m. tensor fascia lata and m. gluteus maximus) will be performed.

Intervention type: PROCEDURE
Intervention: Muscle biopsy
Description: Muscle biopsy of the m. gastrocnemius will be performed under local anesthesia using the modified Bergström technique.

Intervention type: PROCEDURE
Intervention: Muscle biopsy
Description: Muscle biopsy of the m. gastrocnemius will be performed under local anesthesia using the modified Bergström technique.

Intervention type: PROCEDURE
Intervention: Muscle biopsy
Description: Muscle biopsy of the m. gastrocnemius will be performed under local anesthesia using the modified Bergström technique.

Intervention type: RADIATION
Intervention: Quantitative peripheral computed tomography (qPCT)
Description: A qPCT scan of the calf will be performed.

Intervention type: RADIATION
Intervention: Quantitative peripheral computed tomography (qPCT)
Description: A qPCT scan of the calf will be performed.

Intervention type: RADIATION
Intervention: Quantitative peripheral computed tomography (qPCT)
Description: A qPCT scan of the calf will be performed.

Intervention type: DEVICE
Intervention: Mechanography
Description: Single two leg jump, multiple one leg hopping, chair rise and sit to stand tests will be performed.
Study: NCT05126082

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PedsBP CDS
Description: The PedsBP CDS is a sophisticated web-based electronic health record (EHR)-linked tool that can be used to address barriers and improve the identification and management of elevated blood pressure (BP) and hypertension (HT) in children and adolescents by providing patient-specific clinical care recommendations in real time and in accordance with national guidelines for BP management in youth.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PedsBP CDS
Description: The PedsBP CDS is a sophisticated web-based electronic health record (EHR)-linked tool that can be used to address barriers and improve the identification and management of elevated blood pressure (BP) and hypertension (HT) in children and adolescents by providing patient-specific clinical care recommendations in real time and in accordance with national guidelines for BP management in youth.
Study: NCT04714476

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Made-to-measure compression garment
Description: Subjects will wear one of two made-to-measure compression garments:~(1) JOBST® Confidence leggins (BT) and (2) JOBST® Confidence Bermuda (ET)
Study: NCT05557227

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1-hour cycling
Description: 60 % VO2 max

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1-hour cycling
Description: 60 % VO2 max

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1-hour cycling
Description: 60 % VO2 max
Study: NCT06519942

Intervention type: DEVICE
Intervention: Mechanography
Description: Single two leg jump, multiple one leg hopping, chair rise and sit to stand tests will be performed.

Intervention type: DEVICE
Intervention: Mechanography
Description: Single two leg jump, multiple one leg hopping, chair rise and sit to stand tests will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiography (ECG)
Description: A 15-minute resting ECG will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiography (ECG)
Description: A 15-minute resting ECG will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiography (ECG)
Description: A 15-minute resting ECG will be performed.

Intervention type: OTHER
Intervention: Questionnaires
Description: Questionnaires will be performed to collect information on medical background (drug use, comorbidities, symptoms of peripheral neuropathy, ...) and lifestyle factors (ethyl consumption, food intake, physical activity, smoking).

Intervention type: OTHER
Intervention: Questionnaires
Description: Questionnaires will be performed to collect information on medical background (drug use, comorbidities, symptoms of peripheral neuropathy, ...) and lifestyle factors (ethyl consumption, food intake, physical activity, smoking).

Intervention type: OTHER
Intervention: Questionnaires
Description: Questionnaires will be performed to collect information on medical background (drug use, comorbidities, symptoms of peripheral neuropathy, ...) and lifestyle factors (ethyl consumption, food intake, physical activity, smoking).

Intervention type: OTHER
Intervention: Anthropometry
Description: Length and hip:waist ratio will be measured. Furthermore, body weight and composition will be determined by bio-impedance measurement. Systolic and diastolic blood pressure (mean of 3 times) will be evaluated.

Intervention type: OTHER
Intervention: Anthropometry
Description: Length and hip:waist ratio will be measured. Furthermore, body weight and composition will be determined by bio-impedance measurement. Systolic and diastolic blood pressure (mean of 3 times) will be evaluated.

Intervention type: OTHER
Intervention: Anthropometry
Description: Length and hip:waist ratio will be measured. Furthermore, body weight and composition will be determined by bio-impedance measurement. Systolic and diastolic blood pressure (mean of 3 times) will be evaluated.
Study: NCT06134518

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The education program
Description: The intervention group will receive the competency-based education program for 1 month at each PHC, after baseline data collection. The education program will be conducted weekly. This education session will be conducted for 4 hours per session, with 20 health cadres in a group per PHC. The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score at the 2nd post-assessment (2 months after being given the education program).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: the initial orientation from the PHCs
Description: the initial orientation from the PHCs
Study: NCT05527015

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bifocal Spectacles
Description: Bifocals with a +3.00 Diopter flat top 35

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Single Vision Lenses
Description: Single vision lens as prescribed by provider
Study: NCT05687851

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab（AK104）
Description: q3w iv

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: EBRT
Description: 45-50.4Gy
Study: NCT05557227

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1-hour cycling
Description: 60 % VO2 max
Study: NCT05961904

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breastmilk
Description: Study group with receive orally 2 ml breast milk before the heel prick.
Study: NCT05687851

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: BT
Description: ≥80Gy
Study: NCT04945681

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine
Description: Mass campaign offering simultaneous pneumococcal conjugate vaccination to all children aged below 15 years of age living in Digaale camp, Somaliland. Children aged below 12 months receive 2 doses of vaccine, spaced 4 weeks apart. All other children receive one dose.
Study: NCT05684237

Intervention type: PROCEDURE
Group type: OTHER
Intervention: HiSMILE treatment option
Description: The non-CE labeled VisuMax treatment option HiSMILE is able to modify the lenticule shape in a way that should lead to a change in spherical aberration postoperatively.
Study: NCT05498610

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480 0389
Description: Participants will get 1 injections of NNC04800389. It will be injected with a needle into a skin fold on the abdomen.~The study will last for a maximum of 72 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480 0389
Description: Participants will get 1 injections of NNC04800389. It will be injected with a needle into a skin fold on the abdomen.~The study will last for a maximum of 72 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480 0389
Description: Participants will get 1 injections of NNC04800389. It will be injected with a needle into a skin fold on the abdomen.~The study will last for a maximum of 72 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Participants will get 1 injections of semaglutide. It will be injected with a needle into a skin fold on the abdomen.~The study will last for a maximum of 72 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Participants will get 1 injections of semaglutide. It will be injected with a needle into a skin fold on the abdomen.~The study will last for a maximum of 72 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Participants will get 1 injections of semaglutide. It will be injected with a needle into a skin fold on the abdomen.~The study will last for a maximum of 72 days
Study: NCT06486025

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: maintenance magnesium sulphate1g/h
Description: Women will receive a routine loading infusion of 5 g of MgSO4 over 20 minutes, followed by a maintenance dose rate of 1 g/h.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: maintenance magnesium sulphate2g/h
Description: Women will receive a routine loading infusion of 5 g of MgSO4 over 20 minutes, followed by a maintenance dose rate of 2 g/h.
Study: NCT04762290

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dance
Description: The intervention is a series of expressive dance movements.

Intervention type: OTHER
Group type: OTHER
Intervention: Dance
Description: The intervention is a series of expressive dance movements.
Study: NCT06477536

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HB0034
Description: 300mg, i.v. Q4W
Study: NCT05722873

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasting arm
Description: Study participants will fast one day per week for 12 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasting arm
Description: Study participants will fast one day per week for 12 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weight maintenance
Description: Study participants will be counseled to maintain body weight

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Counseling
Description: Study participants will be counseled on optimal diet and activity recommendations for maintaining/achieving a normal BMI
Study: NCT05304039

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Questionnaires about asthma control and quality of life

Intervention type: DEVICE
Intervention: Spirometry
Description: Spirometry monitoring at home

Intervention type: DEVICE
Intervention: Fractional Exhaled Nitric Oxide (FeNO)
Description: Measuring fractional exhaled nitric oxide at home

Intervention type: DEVICE
Intervention: Corsano watch
Description: Monitoring vital parameters at home

Intervention type: DEVICE
Intervention: e-Nose
Description: Breathprint will be performed using e-Nose

Intervention type: PROCEDURE
Intervention: Nasopharyngeal swabs and nasal lining fluid
Description: Nasopharyngeal swabs and nasal lining fluid will be performed

Intervention type: DEVICE
Intervention: Sputum culture
Description: If patients produce sputum, the sputum will be analysed

Intervention type: PROCEDURE
Intervention: Blood sample
Description: Blood sample for standard care and 10 ml extra will be taken
Study: NCT05514977

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector spine plane block
Description: Thoracic ESPB

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector spine plane block
Description: Thoracic ESPB
Study: NCT05003440

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0385-0434
Description: Participants will get 1 tablet (oral use) of NNC0385-0434 per day for 10 days in either 15, 40 or 100 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0385-0434
Description: Participants will get 1 tablet (oral use) of NNC0385-0434 per day for 10 days in either 15, 40 or 100 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0385-0434
Description: Participants will get 1 tablet (oral use) of NNC0385-0434 per day for 10 days in either 15, 40 or 100 mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will get 1 tablet (oral use) of placebo per day for 10 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will get 1 tablet (oral use) of placebo per day for 10 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will get 1 tablet (oral use) of placebo per day for 10 days
Study: NCT06066450

Intervention type: DEVICE
Intervention: Genoss® DES system, Genoss® Osfit system
Description: This is a drug-eluting stent used to improve the diameter of the coronary artery in patients with symptomatic ischemic heart disease, with de novo lesions in the native coronary artery, where the reference vessel diameter ranges from 2.25mm to 5.00mm.
Study: NCT05765162

Intervention type: BEHAVIORAL
Intervention: Patient reported ourcomes
Description: Full screening for the perioperative periode
Study: NCT05274152

Intervention type: DEVICE
Group type: OTHER
Intervention: Immersive Virtual Reality Lower Limb and Knee Rehabilitation
Description: Patients wore a VR headset while undergoing their rehabilitation session

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality Lower Limb and Knee Rehabilitation
Description: Patients wore a VR headset while undergoing their rehabilitation session
Study: NCT06095700

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: first rib resection
Description: standard first rib resection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: First rib avulsion
Description: As the active treatment, just instead of resectioning the first rib, we will do an avulsion of the first rib through the same incision
Study: NCT05867563

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2103 for injection
Description: TQB2103 for injection is an antibody-drug conjugate targeting CLDN18.2. The drug structure mainly includes anti-humanized CLDN 18.2 antibody, linker and cytotoxic DDDXD, with Drug antibody Ratio (DAR) of 8.
Study: NCT05308238

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention group
Description: Participants will receive 6 telehealth coaching sessions and 8 brief email or text check-ins over the course of 4 months. Participants will also receive a Fitbit and Engage PD Workbook.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Disease management education group
Description: Participants will receive online educational videos that they can watch at their own convenience over the course of 4 months. There will be up to 6 hours of content, and the links to these online videos will be provided via email. Following completion of the study, individuals in this group will receive an Engage PD Workbook and one OT coaching session, if they choose to.